MARYKATE MORCERF: Open Payments
NPI 1639745581 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$704 in 33 payments from 22 companies in 2025. Trend: 2023 $815 · 2024 $18 · 2025 $704
Food & beverage: $704
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $102 |
| Daiichi Sankyo Inc. | 3 | $68 |
| E.R. Squibb & Sons, L.L.C. | 3 | $48 |
| ABBVIE INC. | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Celgene Corporation | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| KYOWA KIRIN, INC. | 1 | $29 |
| PharmaEssentia USA Corporation | 1 | $28 |
| Eisai Inc. | 1 | $27 |
Products named: KISQALI, REBLOZYL, DATROWAY, DARZALEX, RYBREVANT, IMBRUVICA, OJJAARA, OPDUALAG.
Industry payments across NC — which companies pay providers there.
